1. HBW Insight

House Hearing Probes FDA’s Cosmetics Role

 
• By Lauren Nardella

Stakeholders from industry, government and FDA discussed ideas for changing the agency’s oversight of cosmetics at a House subcommittee meeting March 27. The need for a national regulatory system, mandatory recalls, company and ingredient registration and adverse event reporting were debated.

Likely signaling an imminent shift in the cosmetics regulatory landscape, legislators and witnesses at a House Energy and Commerce Committee cosmetics hearing spoke to the need for increased FDA regulatory responsibilities and changes to the status quo.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America